MIGRAINE - RECENT DEVELOPMENTS AND FUTURE OPPORTUNITIES

Anjali Patel*, Mayuri Pathak, Suhani Barot, Dhruvi Modi, Dr. Khushbu Patel and Dr. C. N. Patel

ABSTRACT

Migraine is a brain disorder that produces a wide array of neurological and systemic symptoms, commonly including severe head pain; sensitivity to lights, sounds, and smells; neck or shoulder pain; ringing in the ears; nausea and vomiting; and irritability. Migraines can be a primary diagnosis or a symptom of an underlying medical (meningitis, hormone changes) or psychological (depression, anxiety disorder, post-traumatic stress disorder) condition. For more than 90% of sufferers, migraines interfere with education, work, or social activities. Four phases have been identified in migraine attacks. The migraine pipeline looks to take advantage of the ever-growing need for novel therapies, as well as innovative delivery systems. Several old drugs are being reworked into new formulations to decrease time to onset, provide localized treatment, and extend duration of action.

Keywords: Migraine, Meningitis, Depression, Novel Therapies, Innovative delivery systems.